Finasteride
For Prostate Cancer
In the Prostate Cancer Prevention Trial, 18,882 men,
age 55 or over, received either finasteride (Proscar) 5 mg/day or placebo.
Finasteride did appear to prevent or delay the appearance of prostate
cancer and to improve urinary flow in the men who took it; however,
men taking finasteride were more likely to suffer sexual dysfunction
and were more likely to get high-grade prostate cancer.
Reference:
Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford
LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan
A, Szczepanek CM, Crowley JJ, Coltman CA Jr: The influence of finasteride
on the development of prostate cancer. N Engl J Med. 2003 Jul 17;349(3):215-24.
Epub 2003 Jun 24.
------------------------------------------
By Bradley Hennenfent,
M.D.
November 21, 2004
© copyright Bradley Hennenfent, M.D.
Message
Board
To learn
more about Prostatitis Research
Today is : November 20, 2008
You
are visitor number:
Disclaimer